MetLife Investment Management, LLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,807,779
-3.2%
148,6660.0%0.01%0.0%
Q2 2023$1,867,245
+15.0%
148,666
+1.5%
0.01%
+16.7%
Q1 2023$1,623,831
-9.2%
146,4230.0%0.01%
-14.3%
Q4 2022$1,787,825
+17.7%
146,423
+0.7%
0.01%
+7.7%
Q3 2022$1,518,769
-2.8%
145,4760.0%0.01%0.0%
Q2 2022$1,562,412
+13.4%
145,4760.0%0.01%
+44.4%
Q1 2022$1,377,658
+25.7%
145,476
+53.3%
0.01%0.0%
Q4 2021$1,095,818
+20.9%
94,8760.0%0.01%
+12.5%
Q3 2021$906,066
-0.9%
94,8760.0%0.01%
-11.1%
Q2 2021$914,605
+10.9%
94,876
+13.7%
0.01%
+12.5%
Q1 2021$824,506
-65.9%
83,452
-20.3%
0.01%
-68.0%
Q4 2020$2,417,477
+51.9%
104,698
-7.1%
0.02%
+47.1%
Q3 2020$1,591,056
-6.4%
112,6810.0%0.02%
-10.5%
Q2 2020$1,699,229
+63.2%
112,6810.0%0.02%
+26.7%
Q1 2020$1,041,172
-5.1%
112,6810.0%0.02%
+36.4%
Q4 2019$1,097,513
+21.4%
112,6810.0%0.01%
+10.0%
Q3 2019$903,702
-30.4%
112,681
+8.3%
0.01%
-28.6%
Q2 2019$1,298,353
+11.4%
104,035
+21.4%
0.01%
+7.7%
Q1 2019$1,165,846
+42.0%
85,7240.0%0.01%
+30.0%
Q4 2018$821,236
-20.8%
85,7240.0%0.01%
-9.1%
Q3 2018$1,036,403
-22.6%
85,7240.0%0.01%
-31.2%
Q2 2018$1,339,000
+3.9%
85,7240.0%0.02%
+6.7%
Q1 2018$1,289,000
+16.3%
85,724
+11.3%
0.02%
+15.4%
Q4 2017$1,108,00076,9880.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Diversified Trust Co 62,695$889,6420.03%
FULTON BANK, N.A. 11,429$162,1770.01%
DnB Asset Management AS 24,836$352,4230.00%
MASSMUTUAL TRUST CO FSB/ADV 78$1,1070.00%
Versant Capital Management, Inc 28$3970.00%
View complete list of AMICUS THERAPEUTICS INC shareholders